Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Oct;164A(10):2633-7.
doi: 10.1002/ajmg.a.36672. Epub 2014 Jul 14.

Prenatal diagnosis of CLOVES syndrome confirmed by detection of a mosaic PIK3CA mutation in cultured amniocytes

Affiliations
Case Reports

Prenatal diagnosis of CLOVES syndrome confirmed by detection of a mosaic PIK3CA mutation in cultured amniocytes

Lisa T Emrick et al. Am J Med Genet A. 2014 Oct.

Abstract

Congenital lipomatous asymmetric overgrowth of the trunk, lymphatic, capillary, venous, and combined-type vascular malformations, epidermal nevi, skeletal and spinal anomalies (CLOVES) syndrome, a segmental overgrowth syndrome, is caused by post zygotic somatic mutations in PIK3CA, a gene involved in the receptor tyrosine kinase phosphatidylinositol 3-kinase (PI3)-AKT growth-signaling pathway. Prenatal ultrasound findings of lymphovascular malformations, segmental overgrowth and skeletal defects can raise suspicion for CLOVES syndrome, but molecular confirmation of PIK3CA mutations on prenatally obtained samples is challenging because of somatic mosaicism. We detected a mosaic disease-causing mutation in PIK3CA by sequencing of DNA extracted from cultured amniotic cells, but not from DNA directly prepared from an amniotic fluid sample in a fetus with prenatally suspected CLOVES syndrome. The infant was born prematurely and displayed severe lymphovascular malformations and segmental overgrowth consistent with a clinical diagnosis of CLOVES syndrome; he passed away at 29 days of life. We discuss the complexities and limitations of genetic testing for somatic mosaic mutations in the prenatal period and highlight the potential need for multiple approaches to arrive at a molecular diagnosis. © 2014 Wiley Periodicals, Inc.

Keywords: lipomatous malformation; mosaicism; prenatal diagnosis; somatic overgrowth; vascular anomalies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
Prenatal images at 27 weeks gestation and postnatal images of the infant after birth at 31 weeks. A: T2-weighted coronal MR image of the fetus at 27 weeks. There is extensive infiltration by the malformations through the subcutaneous tissues of the abdominal wall, from the axillae to the pelvis, including the dorsal upper thigh on the left. Macrocystic structures are noted (arrows), and there is large-volume ascites. B: Maximum Intensity Projection (MIP) T2-weighted MR image of the limb overgrowth affecting the left foot, with wide-spaced macrodactyly. Multiple sequences showed enlargement of the entire left lower extremity compared with the right, though without abnormal high signal that would indicate infiltration by a mass in the lower leg. C: One day-old infant with bilateral asymmetric overgrowth of the chest and abdomen, bilateral linear epidermal nevi. D: Asymmetric overgrowth of left lower limb, showing macrodactyly, furrowed foot sole and a sandal gap between first and second toes.
Fig. 2
Fig. 2
The PIK3CA c.1624G>A (p.E542K) mutation detected in this patient using Next Generation Sequencing. The data are visualized in the Integrative Genomics Viewer (IGV)(top) and confirmed by Sanger sequencing (bottom).

Comment in

References

    1. Alomari AI. Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of CLOVES syndrome. Clin Dysmorphol. 2009;18:1–7. - PubMed
    1. Biesecker LG, Sapp JC. Proteus Syndrome. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. GeneReviews(R) [Internet] Seattle (WA): University of Washington, Seattle; 2012. 1993–2014. Available from http://www.ncbi.nlm.nih.gov/books/NBK99495/
    1. Grzeschik KH, Bornholdt D, Oeffner F, Konig A, del Carmen Boente M, Enders H, Fritz B, Hertl M, Grasshoff U, Hofling K, Oji V, Paradisi M, Schuchardt C, Szalai Z, Tadini G, Traupe H, Happle R. Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasia. Nat Genet. 2007;39:833–835. - PubMed
    1. Gucev ZS, Tasic V, Jancevska A, Konstantinova MK, Pop-Jordanova N, Trajkovski Z, Biesecker LG. Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE) syndrome: CNS malformations and seizures may be a component of this disorder. Am J Med Genet Part A. 2008;146A:2688–2690. - PMC - PubMed
    1. Iacobas I, Burrows PE, Adams DM, Sutton VR, Hollier LH, Chintagumpala MM. Oral rapamycin in the treatment of patients with hamartoma syndromes and PTEN mutation. Pediatr Blood Cancer. 2011;57:321–323. - PubMed

Publication types

Substances

Supplementary concepts